XOMA (NASDAQ:XOMA) Given Buy Rating at HC Wainwright
HC Wainwright reissued their buy rating on shares of XOMA (NASDAQ:XOMA – Free Report) in a report issued on Wednesday morning,Benzinga reports. HC Wainwright currently has a $104.00 price objective on the biotechnology company’s stock. Separately, StockNews.com lowered XOMA from a “hold” rating to a “sell” rating in a research report on Tuesday, February 25th. […]
